Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy
Cancer Research and Treatment. 2022;54(3):894-906 
Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy
Frontiers in Immunology. 2023;13:
Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression
Genes. 2019;10(6):464
Immunotherapy for Metastatic Urothelial Carcinoma
Bladder Cancer. 2021;305-313
Urethral urothelial carcinoma associated with bladder urothelial carcinoma
Uropathology. 2023;584-585
Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder
. 2021;
Urothelial bladder carcinoma: massive parallel sequencing provides new opportunities for improved patient management
New Biotechnology. 2012;29:S14
Histologic Variants of Urothelial Carcinoma: Morphology, Molecular Features and Clinical Implications
Bladder Cancer. 2020;6(2):107-122
A prospective pilot evaluation of urinary and immunohistochemical markers as predictors of clinical stage of urothelial carcinoma of the bladder
BJU International. 2000;85(9):1027-1032
Genomic Analysis and Treatment Response of a Bladder Urothelial Carcinoma With Sarcomatoid Variant Histology
Clinical Genitourinary Cancer. 2019;17(5):e888-e892